Rhinovirus

PreclinicalBiologic

UUniversity of Virginia

Rhinovirus is one of 68 biologic programs targeting Asthma. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AsthmaActive, not recruiting

ChildrenUnknown status

RhinovirusCompleted

AsthmaPreclinical

Active, not recruiting

ChildrenPreclinical

Unknown status

RhinovirusPreclinical

Completed

Competition

Competitive Landscape

175 competitors in Asthma

#DrugCompanyPhaseTrials

Celexa

AbbVie

Preclinical

1 2

Arcoxia

Novartis

Preclinical

—3

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

1 4

DUPIXENT

Regeneron

Preclinical

1 5

Paracetamol

GSK

Preclinical

1 6

Blood Withdrawn

Emergent BioSolutions

Preclinical

1 7

Aclidinium Bromide

Atrovent

2 9

Blood Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

1 10

Lexapro

SShirley Ryan AbilityLab

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Rhinovirus2 trials

Clinical Response to Rhinovirus Challenge

Completed·UUniversity of Virginia·Phase 2·NCT02910401·38 enrolled

Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)

Completed·UUniversity of Virginia·N/A·NCT01669603·789 enrolled

Asthma2 trials

Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus

Completed·UUniversity of Virginia·Phase 2·NCT02388997·31 enrolled

Evaluating the Asthmatic Response to an Experimental Infection With Rhinovirus in the Atopic

Completed·UUniversity of Virginia·N/A·NCT02111772·26 enrolled

Children1 trial

Virus and Bronchial Epithelium in Children and the Elderly

Unknown status·UUniversity Hospital, Bordeaux·N/A·NCT06224062·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Rhinovirus. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Rhinovirus compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Rhinovirus. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Virginia company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Virginia

Rhinovirus

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Rhinovirus2 trials

Asthma2 trials

Children1 trial

References

Drug Info

Quick Facts

Related News